---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015115"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:37:45.729763+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Vivos closes $6M+stock acquisition of Sleep Center of Nevada; secures $11M+ financing

## Summary
- Acquired SCN for $6M cash + $1.5M in stock (607,287 shares) + assumption of liabilities; up to $1.5M earn-out in stock.
- Senior secured loan of $8.25M from Streeterville Capital (9% interest, 18-month maturity) netted $7.5M to Vivos.
- PIPE from New Seneca affiliate: 828K shares, pre-funded warrant for 725K shares, and 5-yr warrant for 2.33M shares at $2.23; total gross ~$3.755M.
- SCN sees ~3,000 new patients/month, annual high-seven-figure revenue; 90% test positive for OSA; Vivos expects to add diagnostic/appliance revenue over 12-18 months.
- Board-certified sleep specialists Dr. Prabhu Rachakonda and Dr. Tara Rachakonda join Vivos; continue practice management.

## SEC filing metadata
- accession: 0001641172-25-015115
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000164117225015115/0001641172-25-015115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000164117225015115/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015115
- JSON: https://secwatch.observer/filing/0001641172-25-015115.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015115.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.